Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Contributions of Glucose and Hemoglobin A1c Measurements in Diabetes Screening

Contributions of Glucose and Hemoglobin A1c Measurements in Diabetes Screening

Authors: Hilborne LH, Bi C, Radcliff J, Kroll MH, Kaufman HK
Am J Clin Pathol. 2021 Aug 31;aqab106. doi: 10.1093/ajcp/aqab106. Online ahead of print.  

Specialties: Endocrinology, Cardiovascular disease

Download key summary

Related content

On-Demand Webinar
Early Identification of Type 2 Diabetes Risk for the Primary Care Setting
Publication
Large-scale retrospective analyses of the effect of iron deficiency anemia on hemoglobin A1c concentrations
Publication
Association between liver and chronic kidney disease on hemoglobin A1c concentrations
Publication
Predictors of lack of glycemic control in persons with type 2 diabetes
Conference Presentation
Participants in Annual Workplace Health Evaluation Program had Lower Risk for Developing Diabetes

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.